TABLE 1.
INCLUSION CRITERIA | EXCLUSION CRITERIA |
---|---|
Acute kidney injury defined according to the KDIGO criteria20 AND Microscopic or macroscopic haematuria confirmed by sediment urine analysis AND Temporal coincidence between AMX/AMX‐CLAV administration and AKI onset |
• concomitant administration of nephrotoxic drugs with a causality assessment equal to or greater than AMX/AMX‐CLAV therapy (according to Naranjo scale)17 • any underlying condition causing acute kidney injury and/or macroscopic haematuria (or red‐coloured urine by itself) (shock, sepsis, urinary tract infection, urological surgery, kidney disease, rhabdomyolysis, haemolysis, rifampicin treatment …) • fever, rash or liver enzyme abnormalities (suggesting hypersensitivity including acute interstitial nephritis) • purpura, arthralgia or bowel angina (suggesting amoxicillin induced leucocytoclastic vasculitis) |
AKI: acute kidney insufficiency; AMX: amoxicillin; AMX‐CLAV: amoxicillin–clavulanate; KDIGO: Kidney Disease Improving Global Outcomes